| 1 |
11050699 | Pharmacodynamic study of low molecular weight dermatan sulphate (Desmin) after a single subcutaneous administration in patients with renal insufficiency. | 2000 Sep |
1 |
| 2 |
9626917 | Desmin (a low molecular weight dermatan sulphate) versus heparin in the treatment of patients with deep venous thrombosis. | 1998 Apr |
2 |
| 3 |
9684733 | Pharmacokinetics of low molecular weight dermatan sulphate (desmin) in different cohorts of patients. | 1998 May 1 |
1 |
| 4 |
9100165 | Efficacy of an intravenous low-molecular-weight dermatan sulphate (Desmin) in patients with acute proximal deep venous thrombosis and silent pulmonary embolism. A pilot study. | 1997 Mar-Apr |
1 |
| 5 |
9352383 | Bioavailability of Desmin, a low molecular weight dermatan sulfate, after subcutaneous administration to healthy volunteers. | 1997 |
2 |
| 6 |
8810655 | Tolerability and clinical efficacy of desmin in the treatment of superficial thrombovaricophlebitis. | 1996 Sep |
1 |
| 7 |
8815578 | Low molecular weight heparin is responsible for the anti-Xa activity of Desmin 370. | 1996 Feb |
1 |
| 8 |
8837309 | Pharmacology of a new low molecular weight dermatan sulphate (Desmin) in healthy volunteers: repeated daily intramuscular administration of 400 mg for a week. | 1996 Jul 1 |
1 |
| 9 |
8845462 | Effects of low-molecular-weight dermatan sulfate on coagulation, fibrinolysis and tissue factor pathway inhibitor in healthy volunteers. | 1996 Jan |
2 |
| 10 |
8533121 | Pharmacology of desmin (low molecular weight dermatan sulphate) in healthy volunteers following intravenous bolus administration of different dosages (200, 400, 800 mg). | 1995 Aug 1 |
2 |
| 11 |
7824960 | Pharmacological activity of a low molecular weight dermatan sulfate (desmin) in healthy volunteers. | 1994 |
1 |